Fetal Bovine Serum Market | Australia and New Zealand would exhibit the highest CAGR of 5.2% by 2030

Australia and New Zealand fetal bovine serum market

Australia and New Zealand fetal bovine serum market

Australia and New Zealand Fetal Bovine Serum Market by Application and End User Opportunity Analysis and Industry Forecast, 2021-2030.

PORTLAND, OREGON, UNITED STATES, July 22, 2022 /EINPresswire.com/ -- Australia and New Zealand fetal bovine serum market size was valued at $20 million in 2020, and is projected to reach $35 million by 2030, registering a CAGR of 5.2% from 2021 to 2030. Biotechnology is the branch of science that deals with the study of living organisms and their use to make technological innovations. Media is a nutrient growth substance provided in laboratory and research settings for growth, proliferation, maintenance, and storage of microorganisms and other cell types such as stem cells, mammalian, and other cell lines. Different culture media are available in the market for various cell cultures to survive and grow in their incubation environment such as lysogeny broth, serum free media, classical media, and chemically defined media. In addition, sera are used as additional growth supplement factors owing to the presence of hormones necessary for cell growth, proliferation, and differentiation of cells.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

Atlas Biologicals
Biological Industries
Bio Techne
Biowest
GE Healthcare
HiMedia Laboratories Pvt. Ltd.
Merck KGaA (Sigma Aldrich)
Pan Biotech
Rocky Mountain Biologicals
Thermo Fisher Scientific Inc.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/14071

𝐆𝐞𝐭 𝐔𝐩 𝐓𝐨 𝟏𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭, 𝐓𝐢𝐥𝐥 𝐭𝐡𝐞 𝐃𝐚𝐭𝐞 𝟐𝟎𝐭𝐡 𝐨𝐟 𝐀𝐮𝐠𝐮𝐬𝐭 𝟐𝟎𝟐𝟐.

𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝗦𝗰𝗲𝗻𝗮𝗿𝗶𝗼:

After its discovery in Wuhan, the disease rapidly spread to other parts of the globe. Moreover, this virus causes various symptoms in patients, which range from common symptoms to serious symptoms. For instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement. Furthermore, the virus has high potential of lethality in geriatric population. On 11th March 2020, the World Health Organization made an assessment that COVID-19 can be characterized as pandemic. In addition, there are only a few vaccines that received emergency approvals for COVID-19 treatment or prevention. Thus, social distancing is observed as the most important measure to stop the spread of this disease. Furthermore, to maintain social distancing, various countries across the world have adopted nationwide lockdowns.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/14071

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘

• By application, the cell culture segment held the largest Australia and New Zealand fetal bovine serum market share in 2020 and is expected to remain dominant during the forecast period.
• By end user, the biotechnology & pharmaceutical segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.
• By application, biopharmaceutical is expected to experience market growth at the highest rate during the forecast period.

By application, cell culture segment accounted for the majority of market share of the market in 2020. This is attributed to the fact bovine serum is used majorly as an additional supplement in the cell culture media. Furthermore, another factor that contributes to the growth of this segment in Australia and New Zealand include the presence of major key players that offer FBS for cell culture techniques. These include Merck KGaA (Sigma Aldrich), Thermo Fischer, and others that provide specialty FBS for use in cell culture.

By end user, the biotechnology & pharmaceutical company segment generated the maximum revenue of in 2020. This segment is anticipated to exhibit prominent growth rate, due to significant rise in R&D for the development of biopharmaceutical drugs and cancer research.

Other major factors that drive the overall FBS market in Australia and New Zealand include increased funding by the government agencies and rise in focus to develop biopharmaceuticals.

𝐖𝐞 𝐚𝐥𝐬𝐨 𝐎𝐟𝐟𝐞𝐫𝐬 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐚𝐧𝐝 𝐂𝐨𝐮𝐧𝐭𝐫𝐲 𝐑𝐞𝐩𝐨𝐫𝐭𝐬-

North America Australia and New Zealand fetal bovine serum Market
Japan Australia and New Zealand fetal bovine serum Market
South Korea Australia and New Zealand fetal bovine serum Market
Singapore Australia and New Zealand fetal bovine serum Market
Australia Australia and New Zealand fetal bovine serum Market
Europe Australia and New Zealand fetal bovine serum Market
China Australia and New Zealand fetal bovine serum Market
Indonesia Australia and New Zealand fetal bovine serum Market
Taiwan Australia and New Zealand fetal bovine serum Market

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Automated Liquid Handling Market

Cancer Tumor Profiling Market

𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.